Bristol-Myers Squibb Company (VIE:BMYS)

Austria flag Austria · Delayed Price · Currency is EUR
37.73
-0.12 (-0.32%)
Last updated: Sep 25, 2025, 1:00 PM CET
-15.03%
Market Cap 76.80B
Revenue (ttm) 40.62B
Net Income (ttm) 4.30B
Shares Out n/a
EPS (ttm) 2.12
PE Ratio 17.86
Forward PE 6.87
Dividend 2.24 (5.93%)
Ex-Dividend Date Jul 3, 2025
Volume n/a
Average Volume 19
Open 37.67
Previous Close 37.85
Day's Range 37.67 - 37.80
52-Week Range 37.73 - 58.44
Beta n/a
RSI 29.90
Earnings Date Oct 30, 2025

About VIE:BMYS

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Vienna Stock Exchange
Ticker Symbol BMYS
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.